Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03065062
Title	Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Dana-Farber Cancer Institute
Indications	head and neck squamous cell carcinoma pancreatic cancer lung squamous cell carcinoma endometrial cancer Advanced Solid Tumor
Therapies	Gedatolisib + Palbociclib
Age Groups:	senior \| adult
Covered Countries	USA